TABLE 4.

Antimicrobial resistance pattern for Gram-negative and Gram-positive bacteria isolated from children admitted with fever from March 2017 to July 2018 in Dar es Salaam, Tanzania.

Antimicrobial agent	Gram-negative bacteria						Gram-positive bacteria
	K. pneumoniae	E. coli	Acinetobacter spp.	Pseudomonas spp.	Others*	Total	S. aureus	Enterococcus spp.
	n = 62	n = 28	n = 10	n = 12	n = 22	n = 134	n = 42	n = 30
	n (%)	n (%)	n (%)	n (%)	n (%)	n (%)	n (%)	n (%)
PN	NT	NT	NT	NT	NT	NT	40 (95.2%)	17 (56.7%)
AMC	NT	NT	NT	NT	NT	NT	0	17 (56.7%)
AMP	NT	NT	NT	NT	NT	NT	NT	18 (60.0%)
CIP	27 (43.5)	11 (39.3)	2 (20.0)	2 (16.7)	2 (9)	44 (32.83)	10 (23.8%)	21 (70.0%)
TZP	40 (64.5)	0 (0.0)	4 (40.0)	0	0	44 (32.83)	NT	NT
TGC	22 (35.5)	1 (3.6)	NT	NT	3 (13.6)	26 (21.31)	NT	0
FOX	1 (1.6)	2 (7.1)	NT	NT	3 (13.6)	5 (4.09)	11 (26.2%)	NT
ATM	50 (80.6)	10 (35.7)	NT	1 (8.3)	2 (9)	63 (50.81)	NT	NT
CAZ	56 (90.3)	10 (35.7)	5 (50.0)	0	2 (9)	73 (54.5)	NT	NT
CTX	56 (90.3)	10 (35.7)	10 (100)	NT	2 (9)	78 (58.2)	11 (26.2%)	NT
SXT	57 (91.9)	22 (78.6)	4 (40.0)	NT	7 (31.8)	90 (73.77)	1 (2.4%)	NT
CN	53 (85.5)	7 (25.6)	4 (40.0)	1 (8.3)	1 (84.5)	66 (49.25)	14 (33.3%)	NT
C	14 (22.6)	4 (14.3)	NT	NT	2 (9)	20 (17.86)	4 (9.5%)	6 (20.0%)
DO	25 (40.3)	0 (0.0)	0	NT	4 (18)	29 (7.38)	10 (23.8%)	10 (33.3%)
LIN	NT	NT	NT	NT	NT	NT	NT	5 (16.7%)
MEM	0 (0.0)	0 (0.0)	2 (20.0)	2 (16.7)	0	4 (2.98)	7 (16.7%)	NT
VAN	NT	NT	NT	NT	NT	NT	0 (0.0)	0 (0.0)

Others* = Salmonella typhi and Salmonella spp., E. cloacae and Serratia spp.; PN, penicillin; AMC, amoxicillin/clavulanic acid; AMP, ampicillin; CIP, ciprofloxacin; TZP, piperacillin/tazobactam; TGC, tigecycline; FOX, cefoxitin; ATM, aztreonam; CAZ, ceftazidime; CTX, cefotaxime; SXT, sulfamethoxazole/trimethoprim; CN, gentamicin; C, chloramphenicol; DO, doxycycline; MEM, meropenem; LIN, linezolid; VAN, vancomycin; NT, not tested.